Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Esophageal Neoplasms and ERCC1[original query] |
|---|
| Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenetics and genomics 2009 Aug 19 (8): 613-25. Bradbury Penelope A, Kulke Matthew H, Heist Rebecca S, Zhou Wei, Ma Clement, Xu Wei, Marshall Ariela L, Zhai Rihong, Hooshmand Susanne M, Asomaning Kofi, Su Li, Shepherd Frances A, Lynch Thomas J, Wain John C, Christiani David C, Liu Geoffr |
| ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2009 Aug 13 (8): 1411-21. Warnecke-Eberz Ute, Vallböhmer Daniel, Alakus Hakan, Kütting Fabian, Lurje Georg, Bollschweiler Elfriede, Wienand-Dorweiler Anke, Drebber Uta, Hölscher Arnulf H, Metzger Ra |
| Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009 May 30 (5): 785-92. Pan Jennifer, Lin Jie, Izzo Julie G, Liu Yang, Xing Jinliang, Huang Maosheng, Ajani Jaffer A, Wu Xife |
| Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC cancer 2011 May 11 (1): 1. Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Phillips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK |
| ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Pharmacogenetics and genomics 2013 Nov 23 (11): 597-604. Rumiato Enrica, Cavallin Francesco, Boldrin Elisa, Cagol Matteo, Alfieri Rita, Basso Daniela, Castoro Carlo, Ancona Ermanno, Amadori Alberto, Ruol Alberto, Saggioro Danie |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population. Thoracic cancer 2015 Nov 6 (6): 741-8. Yu Xian, Xiao He, Zhao Baojian, Zhang Xu, Wang |
| Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis. Medicine 2015 Sep 94 (39): e1593. Qixing Mao, Gaochao Dong, Wenjie Xia, Rong Yin, Feng Jiang, Lin Xu, Mantang Qiu, Qiang Ch |
| Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study. Annals of surgery 2016 Nov 264 (5): 839-846. Bollschweiler Elfriede, Hölscher Arnulf H, Herbold Till, Metzger Ralf, Alakus Hakan, Schmidt Henner, Drebber Uta, Warnecke-Eberz U |
| A germline predictive signature of response to platinum chemotherapy in esophageal cancer. Translational research : the journal of laboratory and clinical medicine 2015 Dec . Rumiato Enrica, Boldrin Elisa, Malacrida Sandro, Battaglia Giorgio, Bocus Paolo, Castoro Carlo, Cagol Matteo, Chiarion-Sileni Vanna, Ruol Alberto, Amadori Alberto, Saggioro Danie |
| Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype. Oncology letters 2018 Aug 16 (2): 2539-2548. Yao Yi-Wei, He Yi-Fu, Han Xing-Hua, Ji Chu-Shu, Hu Bi |
| Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer. Frontiers in oncology 2019 9 85. Boldrin Elisa, Malacrida Sandro, Rumiato Enrica, Battaglia Giorgio, Ruol Alberto, Amadori Alberto, Saggioro Danie |
| Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis. Oncology research and treatment 2020 Jan 1-9. Zhuo Ze-Guo, Zhu Yun-Ke, Deng Han-Yu, Li Gang, Luo Jun, Alai Gu-Ha, Lin Yi-D |
| Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. International journal of cancer 2022 Oct . Ma Yueyun, Li Wenjie, Chen Shiyu, Lin Shuimiao, Ding Sijie, Zhou Xiaomei, Liu Tongxin, Wang Rong, Wang W |
| Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population. PloS one 2023 5 18 (5): e0284825. Xiaoqing Wu, Wenping Lu, Cuihong Jiang, Dongni Zhang, Weixuan Zhang, Yongjia Cui, Zhili Zhuo, Heting Mei, Ya'nan Wang, Mengfan Zhang, Shuntai Ch |
- Page last reviewed:Feb 1, 2024
- Content source: